Trial Profile
A Randomized, Crossover, Placebo Controlled, Double-blind Trial of the Effect of STIOLTO RESPIMAT on Central and Peripheral Components of Fatigue During Exercise in Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2020
Price :
$35
*
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease; Fatigue
- Focus Therapeutic Use
- 10 Aug 2018 Status changed from recruiting to completed.
- 16 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 16 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.